DOD Biotech PCL (DOD) Stock Price & News

All values in THB	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	149,98 m	144,94 m	122,55 m	125,61 m
Cost of goods sold	91,35 m	96,77 m	93,32 m	84,63 m
Cost of revenue	91,35 m	96,77 m	93,32 m	84,63 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	48,64 m	46,27 m	41,73 m	40,91 m
Operating expense	48,64 m	46,27 m	41,73 m	40,91 m
Total operating expenses	139,99 m	143,05 m	135,05 m	125,54 m
Operating income	9,99 m	1,89 m	-12,50 m	71,00 k
Other non operating income	-	-	-	-
EBT including unusual items	12,25 m	1,67 m	-21,40 m	2,61 m
EBT excluding unusual items	9,72 m	1,56 m	-13,17 m	-527,00 k
Income tax expense	1,96 m	-10,99 m	-1,17 m	545,00 k
Effective tax rate	15,98%	-657,37%	5,46%	20,87%
Other operating expenses	-	-	-	-
Net income	10,02 m	12,78 m	-21,87 m	941,00 k
Net profit margin	6,68%	8,82%	-17,85%	0,75%
Earnings per share	-	-	-	-
Interest and investment income	496,00 k	588,12 k	226,00 k	264,00 k
Interest expense	-767,00 k	-913,06 k	-899,00 k	-862,00 k
Net interest expenses	-271,00 k	-324,94 k	-673,00 k	-598,00 k
Depreciation and amortization charges	-	-	-	-
EBITDA	20,62 m	11,30 m	-1,33 m	11,54 m
Gain or loss from assets sale	11,00 k	-2,05 k	247,00 k	-

Ask anything